Flexima™ Biliary M00539310Recalls & reported problems
Boston Scientific Corporation · Biliary Stent with Delivery System · Class 2 · Implant
All models of Flexima Biliary (15)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 9
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 9 adverse event reports that list this exact device (DI 08714729162629), received between Sep 14, 2019 and Sep 25, 2025 — classified as 9 malfunctions.
The most frequently reported specific device problem is “Break” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Break4
- Adverse Event Without Identified Device or Use Problem2
- Difficult to Advance2
- Unsealed Device Packaging2
- Activation, Positioning or Separation Problem1
- Material Split, Cut or Torn1
- Migration1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- No Consequences Or Impact To Patient3
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 9 most recent of 9 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 25, 2025Break; Difficult to Advance; Adverse Event Without Identified Device or Use Problem; Break; Difficult to Advance; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA BILIARY STENT WAS TO BE IMPLANTED TO TREAT OBSTRUCTIVE JAUNDICE IN THE COMMON BILE DUCT PROCEDURE PERFORMED ON (B)(6) 2025. DURING THE PROCEDURE, SEVERE RESISTANCE WAS ENCOUNTERED AT THE MID BILE DUCT STENOSIS. THE DEVICE WAS REMOVED FOR BALLOON DILATATION, DURING WHICH A SNAPPING SOUND WAS HEARD. THE STENT AND DELIVERY SYSTEM COULD NOT BE RETRIEVED TOGETHER; THE DELIVERY SYSTEM WAS REMOVED FIRST, FOLLOWED BY THE STENT. THE INNER CATHETER APPEARED TO HAVE EXTENDED SEVERAL CENTIMETERS WITHOUT INTENTIONAL RELEASE. ANOTHER FLEXIMA BILIARY STENT WAS USED TO COMPLETE THE PROCEDURE THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23145327 ↗MalfunctionMar 4, 2025Activation, Positioning or Separation Problem; Adverse Event Without Identified Device or Use Problem; Material Split, Cut or Torn; Activation, Positioning or Separation Problem; Adverse Event Without Identified Device or Use Problem; Material Split, Cut or Torn
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA BILIARY STENT WAS IMPLANTED DURING A BILE DUCT STENT PLACEMENT PROCEDURE PERFORMED ON (B)(6) 2025. DURING THE PROCEDURE, WHEN THE DEVICE WAS PASSED OVER THE GUIDEWIRE AND REACHED THE PAPILLA, IT HAD ALREADY BEEN RELEASED. HOWEVER, THE SUTURE THREAD REMAINED ON THE STENT. ADDITIONALLY, THE FLAP ON THE HILAR SIDE HAD BEEN CUT (IT WAS NOT DISLODGED INSIDE THE PATIENT). THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. ADDITIONAL INFORMATION RECEIVED ON MARCH 26, 2020. THE FLEXIMA BILIARY STENT WAS PLACED TO TREAT A STRICTURE IN THE COMMON BILE DUCT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21520837 ↗MalfunctionJan 4, 2024Unsealed Device Packaging; Unsealed Device Packaging
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA BILIARY PRE-LOADED STENT WAS TO BE USED DURING A PROCEDURE ON AN UNKNOWN DATE. DURING PREPARATION, THE PACKAGING SEAL HAS PEELED OFF AND HAS STUCK TO ANOTHER PRODUCT UPON OPENING THE PACKAGE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18446494 ↗MalfunctionJun 9, 2023Difficult to Advance; Difficult to Advance
IT WAS REPORTED TO BOSTON SCIENTIFIC THAT A FLEXIMA BILIARY STENT WAS ATTEMPTED TO BE PLACED IN THE DISTAL BILE DUCT DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE PERFORMED ON (B)(6) 2023. DURING THE PROCEDURE, AFTER THE GUIDEWIRE WAS CORRECTLY POSITIONED, AN ATTEMPT WAS MADE TO CROSS THE STENOSIS, BUT DESPITE SEVERAL MANEUVERS, THE PHYSICIAN WAS UNABLE TO CROSS THE STENOSIS. AFTER SEVERAL ATTEMPTS, THE PROCEDURE WAS CANCELLED. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT CONDITION AFTER THE PROCEDURE WAS REPORTED TO BE STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17100632 ↗MalfunctionJan 12, 2022Unsealed Device Packaging; Unsealed Device Packaging
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA PRELOADED BILIARY STENT WAS USED DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PROCEDURE IN THE COMMON BILE DUCT, PERFORMED ON (B)(6) 2021. DURING UNPACKING, THE PACKAGING WAS FOUND DAMAGED. THE STERILITY OF THE DEVICE WAS COMPROMISED. ANOTHER FLEXIMA BILIARY STENT WAS OPENED AND SUCCESSFULLY COMPLETED THE PROCEDURE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13236872 ↗MalfunctionAug 26, 2020Break; Break
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA BILIARY STENT WAS USED DURING AN ENDOSCOPIC BILIARY STENT PLACEMENT PROCEDURE IN THE BILE DUCT PERFORMED ON (B)(6)2020. ACCORDING TO THE COMPLAINANT, DURING THE PROCEDURE, WHEN THE STENT WAS RELEASED FOR DEPLOYMENT, THE GUIDE CATHETER BECAME SEPARATED FROM THE TOUHY BORST. HOWEVER, WHEN THE GUIDE CATHETER WAS REMOVED, THE STENT WAS DEPLOYED SUCCESSFULLY WITHOUT PROBLEM. REPORTEDLY, THE BROKEN GUIDE CATHETER REMAINED WITHIN THE PUSH CATHETER ENABLING THE DELIVERY SYSTEM TO BE REMOVED IN ONE PIECE. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10454804 ↗MalfunctionFeb 18, 2020Break; Break
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA BILIARY STENT WAS USED DURING A PROCEDURE PERFORMED ON (B)(6) 2020. ACCORDING TO THE COMPLAINANT, WHEN THE STENT WAS INSERTED INTO THE ENDOSCOPE DURING THE PROCEDURE, THE STENT DEPLOYED PREMATURELY. WHEN THE FLEXIMA BILIARY STENT WAS WITHDRAWN OUT FROM THE SCOPE, IT WAS NOTICED THAT THE GUIDE CATHETER WAS BROKEN AND THE STENT BARB WAS SEVERELY BENT. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH ANOTHER FLEXIMA BILIARY STENT. THERE WAS NO SERIOUS INJURY, NOR WERE THERE ANY ADVERSE PATIENT EFFECTS REPORTED AS A RESULT OF THIS EVENT. BOSTON SCIENTIFIC HAS BEEN UNABLE TO OBTAIN ADDITIONAL INFORMATION REGARDING THE EVENT TO DATE, DESPITE GOOD FAITH EFFORTS.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9720206 ↗MalfunctionNov 12, 2019Migration; Migration
IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA BILIARY STENT WAS IMPLANTED DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) PROCEDURE IN THE COMMON BILE DUCT PERFORMED ON (B)(6) 2019. ON (B)(6) 2019, THE FLEXIMA BILIARY STENT WAS IMPLANTED FOR CBD DILATION AND JAUNDICE. ACCORDING TO THE COMPLAINANT, IT WAS REPORTED THE PATIENT WAS BROUGHT BACK TO THE HOSPITAL ON (B)(6) 2019 FOR SPYGLASS PROCEDURE, THE PHYSICIAN DISCOVERED THAT THE STENT HAD MIGRATED OUT OF THE COMMON BILE DUCT. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE PATIENT'S CONDITION AT THE CONCLUSION OF THE PROCEDURE WAS REPORTED TO BE FINE. BOSTON SCIENTIFIC HAS BEEN UNABLE TO OBTAIN ADDITIONAL INFORMATION REGARDING THE EVENT TO DATE, DESPITE GOOD FAITH EFFORTS. ADDITIONAL INFORMATION RECEIVED ON 22NOV2019 WHEN THE PHYSICIAN REACHED THE PAPILLA, THE STENT WAS GONE. THE PHYSICIAN THOUGHT THE STENT PASSED THROUGH THE PATIENT NATURALLY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9311930 ↗MalfunctionSep 14, 2019Break; Break
NOTE: THIS REPORT IS ONE OF TWO COMPLAINTS THAT PERTAIN TO THE SAME EVENT (MFR. REPORT # 3005099803-2019-04575). IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A FLEXIMA BILIARY STENT WAS USED DURING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PROCEDURE IN THE BILIARY DUCT, PERFORMED ON (B)(6) 2019. ACCORDING TO THE COMPLAINANT, DURING THE PROCEDURE WHILE THE PHYSICIAN ATTEMPTED TO RELEASE THE STENT, THE SUTURE RELEASED PROPERLY BUT IT FAILED TO DEPLOY. THE DEVICE WAS NOTED TO BE 'DAMAGED'. CANNULATION WAS PERFORMED AND ANOTHER ATTEMPT WAS MADE USING A NEW FLEXIMA BILIARY STENT HOWEVER, THE SAME PROBLEM OCCURRED. FINALLY, A THIRD FLEXIMA BILIARY STENT WAS USED, YET THE STENT FAILED TO DEPLOY. THE PROCEDURE WAS COMPLETED USING A FOURTH BILIARY STENT. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. A PHOTO OF THE COMPLAINT DEVICE WAS PROVIDED AND SHOWED THE PROXIMAL END OF THE GUIDE CATHETER WAS DETACHED WHILE THE REST OF THE GUIDE CATHETER APPEARED TO HAVE REMAINED WITHIN THE PUSH CATHETER.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9056450 ↗
Other CATHETER, BILIARY, DIAGNOSTIC devices
- Hurricane™ RX M00545900Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls1 death705 reports
- MUSTANG™ H74939171060470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC384 reports
- CRE™ PRO M00558710Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC1 recall284 reports
- Hurricane™ RX M00545920Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls211 reports
- MUSTANG™ H74939171070470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC265 reports
- MUSTANG™ H74939171050470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC212 reports
- Hurricane™ RX M00545940Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls109 reports
- MUSTANG™ H74939171100470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC203 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page